Europe Nuclear Medicine Market Outlook (2014-2022)

September 2015 | 104 pages | ID: EDDF727C4DDEN
Stratistics Market Research Consulting

Abstracts

The “Europe Nuclear Medicine Market” report provides an in-depth analysis of the various market segments and its sub-segments. The Nuclear Medicine market is segmented by application and by geography. Based on the application, the nuclear medicine market is categorized into diagnostics and therapeutics applications. The diagnostic application is further segmented into SPECT and PET market, where SPECT market comprises cardiology, neurology, thyroid and other diagnostic applications. The PET market comprises oncology and other PET applications. The therapeutics application is further segmented into thyroid, bone metastasis, endocrine tumors and other therapeutic applications. Based on the geography the market is categorized Germany, France, Italy, Spain, UK and Rest of Europe.

The report focuses on current and upcoming market trends such as Drivers, Constraints, Opportunities, and Challenges, technological advancements, Porters Five Forces analysis to assess the intensity of competition in the market. The market values are presented in the form of tables and graphs for better interpretation.

Market Size Estimations

The market assessment is made by the core industry experts using our 360° research approach. The data is derived from the most reliable, authenticated data sources and is validated by the industry experts (Primary Research). Both top down and bottom up analysis are implemented to enhance the accuracy of the market figures. The market projections are calculated for the next 8 years using the actual market numbers of previous year as the base year.

Company Profiling

This section provides the overview of the key players that are leading in the industry, covering their business operations, financials, list of products & services, SWOT analysis, major developments such as mergers & acquisitions, agreements, partnerships, joint ventures, new product launch, expansions etc.

Report Highlights:

• Market share assessments for all the mentioned market segments and sub-segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 8 years for all the given segments
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping, mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Contents

1 EXECUTIVE SUMMARY

2 PREFACE

2.1 Abstract
2.2 Research Scope
2.3 Research Methodology
2.4 Research Sources

3 MARKET TREND ANALYSIS

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats

4 PORTERS FIVE FORCE ANALYSIS

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 EUROPE NUCLEAR MEDICINE MARKET BY, COCKPIT APPLICATIONS

5.1 Introduction
5.2 Diagnostics
  5.2.1 Single proton emission tomography (SPECT)
    5.2.1.1 Cardiology
    5.2.1.2 Neurology
    5.2.1.3 Thyroid
    5.2.1.4 Other SPECT applications
  5.2.2 Positron emission tomography (PET)
    5.2.2.1 Oncology
    5.2.2.2 Other PET applications
5.3 Therapeutics
  5.3.1 Thyroid
  5.3.2 Bone metastasis
  5.3.3 Endocrine tumors
  5.3.4 Other therapeutic applications

6 EUROPE NUCLEAR MEDICINE MARKET, BY GEOGRAPHY

6.1 Europe
  6.1.1 Germany
  6.1.2 France
  6.1.3 Italy
  6.1.4 UK
  6.1.5 Spain
  6.1.6 Rest of Europe

7 KEY DEVELOPMENTS

7.1 Agreements, Partnerships, Collaborations and Joint Ventures
7.2 Acquisitions & Mergers
7.3 New Product Launch
7.4 Expansions
7.5 Other Key Strategies
7.4 Expansions
7.5 Other Key Strategies

8 COMPANY PROFILING

8.1 GE Healthcare (U.K.)
8.2 Nordion, Inc. (Canada)
8.3 Bayer Healthcare (Germany)
8.4 Cardinal Health, Inc. (U.S.)
8.5 Siemens Healthcare (PETNET) (Germany)
8.6 IBA Group (Belgium)
8.7 Lantheus Medical Imaging, Inc. (U.S.)
8.8 Eczacibasi-Monrol Nuclear Products (Turkey)

List Of Tables

LIST OF TABLES

1 Europe Nuclear Medicin Market Outlook, By Countries (2012-2022) ($MN)
2 Europe Nuclear Medicine Market Outlook, By Applications (2012-2022) ($MN)
3 Germany Nuclear Medicine Market Outlook, By Applications (2012-2022) ($MN)
4 France Nuclear Medicine Market Outlook, By Applications (2012-2022) ($MN)
5 Italy Nuclear Medicine Market Outlook, By Applications (2012-2022) ($MN)
6 SpainNuclear Medicine Market Outlook, By Applications (2012-2022) ($MN)
7 UKNuclear Medicine Market Outlook, By Applications (2012-2022) ($MN)
8 Rest of Europe Nuclear Medicine Market Outlook, By Applications (2012-2022) ($MN)
9 Europe Nuclear Medicine Market Outlook, By Diagnostics (2012-2022) ($MN)
10 Europe Nuclear Medicine Market Outlook, By Single proton emission tomography (SPECT) (2012-2022) ($MN)
11 Europe Nuclear Medicine Market Outlook, By Cardiology (2012-2022) ($MN)
12 Europe Nuclear Medicine Market Outlook, By Neurology (2012-2022) ($MN)
13 Europe Nuclear Medicine Market Outlook, By Thyroid (2012-2022) ($MN)
14 Europe Nuclear Medicine Market Outlook, By Other SPECT applications (2012-2022) ($MN)
15 Europe Nuclear Medicine Market Outlook, By Positron emission tomography (PET) (2012-2022) ($MN)
16 Europe Nuclear Medicine Market Outlook, By Oncology (2012-2022) ($MN)
17 Europe Nuclear Medicine Market Outlook, By Other PET applications (2012-2022) ($MN)
18 Europe Nuclear Medicine Market Outlook, By Therapeutics (2012-2022) ($MN)
19 Europe Nuclear Medicine Market Outlook, By Thyroid (2012-2022) ($MN)
20 Europe Nuclear Medicine Market Outlook, By Bone metastasis (2012-2022) ($MN)
21 Europe Nuclear Medicine Market Outlook, By Endocrine tumors (2012-2022) ($MN)
22 Europe Nuclear Medicine Market Outlook, By Other therapeutic applications (2012-2022) ($MN)